nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—Tumour pain—Topotecan—cervical cancer	0.21	0.286	CcSEcCtD
Letrozole—CYP3A4—Topotecan—cervical cancer	0.208	1	CbGbCtD
Letrozole—CYP19A1—semen—cervical cancer	0.0301	0.509	CbGeAlD
Letrozole—Rash erythematous—Topotecan—cervical cancer	0.0258	0.0352	CcSEcCtD
Letrozole—Pleural effusion—Topotecan—cervical cancer	0.0258	0.0352	CcSEcCtD
Letrozole—Bone pain—Topotecan—cervical cancer	0.0206	0.0281	CcSEcCtD
Letrozole—Pulmonary embolism—Topotecan—cervical cancer	0.0198	0.027	CcSEcCtD
Letrozole—Rash maculo-papular—Topotecan—cervical cancer	0.018	0.0245	CcSEcCtD
Letrozole—Neoplasm—Topotecan—cervical cancer	0.0179	0.0244	CcSEcCtD
Letrozole—Lethargy—Topotecan—cervical cancer	0.0146	0.02	CcSEcCtD
Letrozole—Weight increased—Topotecan—cervical cancer	0.0113	0.0154	CcSEcCtD
Letrozole—Infestation NOS—Topotecan—cervical cancer	0.0111	0.0151	CcSEcCtD
Letrozole—Infestation—Topotecan—cervical cancer	0.0111	0.0151	CcSEcCtD
Letrozole—Stomatitis—Topotecan—cervical cancer	0.0108	0.0147	CcSEcCtD
Letrozole—Sweating—Topotecan—cervical cancer	0.0106	0.0145	CcSEcCtD
Letrozole—Hepatobiliary disease—Topotecan—cervical cancer	0.0105	0.0143	CcSEcCtD
Letrozole—Haemoglobin—Topotecan—cervical cancer	0.00997	0.0136	CcSEcCtD
Letrozole—Haemorrhage—Topotecan—cervical cancer	0.00992	0.0135	CcSEcCtD
Letrozole—Hypoaesthesia—Topotecan—cervical cancer	0.00987	0.0135	CcSEcCtD
Letrozole—Angiopathy—Topotecan—cervical cancer	0.009	0.0123	CcSEcCtD
Letrozole—Mediastinal disorder—Topotecan—cervical cancer	0.00894	0.0122	CcSEcCtD
Letrozole—Alopecia—Topotecan—cervical cancer	0.00877	0.012	CcSEcCtD
Letrozole—Malnutrition—Topotecan—cervical cancer	0.00864	0.0118	CcSEcCtD
Letrozole—Back pain—Topotecan—cervical cancer	0.00836	0.0114	CcSEcCtD
Letrozole—Ill-defined disorder—Topotecan—cervical cancer	0.00801	0.0109	CcSEcCtD
Letrozole—Angioedema—Topotecan—cervical cancer	0.00789	0.0108	CcSEcCtD
Letrozole—Malaise—Topotecan—cervical cancer	0.00779	0.0106	CcSEcCtD
Letrozole—Leukopenia—Topotecan—cervical cancer	0.00773	0.0105	CcSEcCtD
Letrozole—Cough—Topotecan—cervical cancer	0.00754	0.0103	CcSEcCtD
Letrozole—Arthralgia—Topotecan—cervical cancer	0.00735	0.01	CcSEcCtD
Letrozole—Chest pain—Topotecan—cervical cancer	0.00735	0.01	CcSEcCtD
Letrozole—Myalgia—Topotecan—cervical cancer	0.00735	0.01	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.0073	0.00996	CcSEcCtD
Letrozole—Discomfort—Topotecan—cervical cancer	0.00727	0.00991	CcSEcCtD
Letrozole—Anaphylactic shock—Topotecan—cervical cancer	0.00705	0.00962	CcSEcCtD
Letrozole—Infection—Topotecan—cervical cancer	0.007	0.00955	CcSEcCtD
Letrozole—Nervous system disorder—Topotecan—cervical cancer	0.00691	0.00943	CcSEcCtD
Letrozole—Skin disorder—Topotecan—cervical cancer	0.00685	0.00934	CcSEcCtD
Letrozole—Hyperhidrosis—Topotecan—cervical cancer	0.00681	0.0093	CcSEcCtD
Letrozole—Anorexia—Topotecan—cervical cancer	0.00672	0.00917	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00642	0.00876	CcSEcCtD
Letrozole—Paraesthesia—Topotecan—cervical cancer	0.00633	0.00864	CcSEcCtD
Letrozole—Dyspnoea—Topotecan—cervical cancer	0.00628	0.00857	CcSEcCtD
Letrozole—Dyspepsia—Topotecan—cervical cancer	0.00621	0.00847	CcSEcCtD
Letrozole—Decreased appetite—Topotecan—cervical cancer	0.00613	0.00836	CcSEcCtD
Letrozole—Gastrointestinal disorder—Topotecan—cervical cancer	0.00609	0.0083	CcSEcCtD
Letrozole—Fatigue—Topotecan—cervical cancer	0.00608	0.00829	CcSEcCtD
Letrozole—Pain—Topotecan—cervical cancer	0.00603	0.00822	CcSEcCtD
Letrozole—Constipation—Topotecan—cervical cancer	0.00603	0.00822	CcSEcCtD
Letrozole—Feeling abnormal—Topotecan—cervical cancer	0.00581	0.00792	CcSEcCtD
Letrozole—Gastrointestinal pain—Topotecan—cervical cancer	0.00576	0.00786	CcSEcCtD
Letrozole—Urticaria—Topotecan—cervical cancer	0.0056	0.00764	CcSEcCtD
Letrozole—Body temperature increased—Topotecan—cervical cancer	0.00557	0.0076	CcSEcCtD
Letrozole—Abdominal pain—Topotecan—cervical cancer	0.00557	0.0076	CcSEcCtD
Letrozole—Asthenia—Topotecan—cervical cancer	0.00506	0.0069	CcSEcCtD
Letrozole—Pruritus—Topotecan—cervical cancer	0.00499	0.0068	CcSEcCtD
Letrozole—CYP19A1—endometrium—cervical cancer	0.00497	0.084	CbGeAlD
Letrozole—Diarrhoea—Topotecan—cervical cancer	0.00482	0.00658	CcSEcCtD
Letrozole—CYP2A6—vagina—cervical cancer	0.00474	0.0803	CbGeAlD
Letrozole—Dizziness—Topotecan—cervical cancer	0.00466	0.00636	CcSEcCtD
Letrozole—CYP19A1—uterus—cervical cancer	0.00458	0.0774	CbGeAlD
Letrozole—Vomiting—Topotecan—cervical cancer	0.00448	0.00611	CcSEcCtD
Letrozole—Rash—Topotecan—cervical cancer	0.00444	0.00606	CcSEcCtD
Letrozole—Dermatitis—Topotecan—cervical cancer	0.00444	0.00606	CcSEcCtD
Letrozole—Headache—Topotecan—cervical cancer	0.00442	0.00602	CcSEcCtD
Letrozole—Nausea—Topotecan—cervical cancer	0.00419	0.00571	CcSEcCtD
Letrozole—CYP19A1—female reproductive system—cervical cancer	0.00411	0.0696	CbGeAlD
Letrozole—CYP19A1—female gonad—cervical cancer	0.00374	0.0634	CbGeAlD
Letrozole—CYP3A4—renal system—cervical cancer	0.00249	0.0422	CbGeAlD
Letrozole—CYP19A1—lymph node—cervical cancer	0.00241	0.0407	CbGeAlD
Letrozole—CYP3A4—female reproductive system—cervical cancer	0.00199	0.0338	CbGeAlD
